Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19

The Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was identified in December 2019. The symptoms include fever, cough, dyspnea, early symptom of sputum, and acute respiratory distress syndrome (ARDS). Mesenchymal stem cell (MSC) therapy is the immediate treatment used for patients with sev...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Med
Autores principales: Tang, Lingling, Jiang, Yingan, Zhu, Mengfei, Chen, Lijun, Zhou, Xiaoyang, Zhou, Chenliang, Ye, Peng, Chen, Xiaobei, Wang, Baohong, Xu, Zhenyu, Zhang, Qiang, Xu, Xiaowei, Gao, Hainv, Wu, Xiaojun, Li, Dong, Jiang, Wanli, Qu, Jingjing, Xiang, Charlie, Li, Lanjuan
Formato: Artigo
Lenguaje:Inglês
Publicado: Higher Education Press 2020
Materias:
Letter to Frontiers of Medicine
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7406954/
https://ncbi.nlm.nih.gov/pubmed/32761491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11684-020-0810-9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares